Download presentation
Presentation is loading. Please wait.
Published byamal saidi Modified over 5 years ago
1
From: The Role of the New β-Blockers in Treating Cardiovascular Disease Am J Hypertens. 2005;18(S6):169S-176S. doi:10.1016/j.amjhyper.2005.09.009 Am J Hypertens | © 2005 by the American Journal of Hypertension, Ltd.American Journal of Hypertension, Ltd. Nebivolol exhibits a greater degree of β1/β2-receptor selectivity compared with..
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.